Maxim Group Reiterates Buy on HeartSciences, Maintains $12 Price Target

Benzinga12/18 22:20

HeartSciences Analyst Ratings

Benzinga12/18 22:19

Heart Test Laboratories Q2 EPS $(2.27) Beats $(2.43) Estimate

Benzinga12/17 05:25

HeartSciences: Saw Across-the-Bd Progress, Positive Developments for Field of AI-ECG, MyoVista WavECG Device, MyoVista Insights Cloud-Native Platform and First Cloud-Based AI-ECG Algorithms >HSCS

Dow Jones12/17 05:23

HeartSciences: No Rev During 2Q FY25. as of Oct 31, 2024, Cash and Cash Equivalents Were Approximately $4.1M and Shareholders' Equity Was Approximately $4.0M >HSCS

Dow Jones12/17 05:23

8-K：HeartSciencesは、ビジネスの最新情報を提供し、2025年度第2四半期の決算を報告します

SEC12/17 05:18